In 2023, the pharmaceutical industry export market share in Sweden stood at 1.67. Based on the forecasted data, significant growth is anticipated over the next five years. The year-on-year variation from 2024 to 2025 is approximately 1.18%, with a similar trend continuing in subsequent years. The Compound Annual Growth Rate (CAGR) over the forecasted period from 2024 to 2028 is projected to be around 0.84%.
Key future trends to watch for:
- Increasing demand for innovative pharmaceutical products.
- Potential impacts of regulatory changes within the European Union.
- Technological advancements in drug development and manufacturing.
- Evolving trade agreements and their implications on export dynamics.
